Zofran and Weight bearing difficulty - a phase IV clinical study of FDA data

Summary:

Weight bearing difficulty is reported as a side effect among people who take Zofran (ondansetron hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Ativan, and have Pain.

The phase IV clinical study analyzes which people have Weight bearing difficulty when taking Zofran. It is created by eHealthMe based on reports of 93,713 people who have side effects when taking Zofran from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Weight bearing difficulty?

Weight bearing difficulty (difficulty due to weight of thigh fat deposition) is found to be associated with 332 drugs and 826 conditions by eHealthMe. Check the latest studies of Weight bearing difficulty.

On Jul, 13, 2026

93,713 people reported to have side effects when taking Zofran.
Among them, 28 people (0.03%) have Weight bearing difficulty.

Could Zofran cause Weight bearing difficulty?

Among these 28 people:

How long have people been on Zofran when they have Weight bearing difficulty? *

What is the gender of people who have Weight bearing difficulty when taking Zofran? *

female: 89.29 %
male: 10.71 %

What is the age of people who have Weight bearing difficulty when taking Zofran? *

What are other drugs people take besides Zofran? *

What are other side effects people have besides Weight bearing difficulty? *

Headache (pain in head): 15 people, 53.57%
Pain: 15 people, 53.57%
Joint Pain: 14 people, 50.00%
Dehydration (dryness resulting from the removal of water): 13 people, 46.43%
Fall: 13 people, 46.43%
Anaemia (lack of blood): 13 people, 46.43%
Back Pain: 13 people, 46.43%
Diarrhea: 12 people, 42.86%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 42.86%
Pain In Extremity: 12 people, 42.86%

What are the existing conditions these people have? *

Pain: 9 people, 32.14%
Breast Cancer Metastatic: 5 people, 17.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 14.29%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 14.29%
Depression: 3 people, 10.71%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 3 people, 10.71%
Headache (pain in head): 2 people, 7.14%
Uterine Haemorrhage (uterine bleeding): 2 people, 7.14%
Neuralgia (pain in one or more nerves): 2 people, 7.14%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and have Weight bearing difficulty?

- Check whether Weight bearing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zofran:

Zofran (94,987 reports)

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight bearing difficulty:

Weight bearing difficulty (332 drugs)

Browse all the conditions that are associated with Weight bearing difficulty:

Weight bearing difficulty (826 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron hydrochloride (the active ingredients of Zofran) and Zofran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.